[120-hour continuous 5-FU infusion and cisplatin in the treatment of advanced esophageal carcinoma--clinical analysis of 19 cases].
From May 1985 to July 1987, 21 patients with advanced esophageal carcinoma without previous chemotherapy were treated with 120-hour continuous 5-FU infusion and Cisplatin. 19 patients received at least one to three cycles of treatment. One achieved complete response (5.5%), 8 partial response (42.1%), 4 no change (22.2%), 6 progressive disease (31.5%). The overall response rate was 47.6% (9/19). The toxic effects were tolerable in most patients. The factors influencing response are discussed. The authors suggest this regime as a palliative treatment or a part of combined therapy for advanced esophageal carcinoma.